title: Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity.
authors.affiliation: Allergy Service, Hospital Doctor Negrín de Gran Canaria, 35010 Las Palmas, Spain.
authors.forename: Isadora
authors.initials: I
authors.lastname: Suárez-Lorenzo
authors.affiliation: Allergy Service, Hospital Doctor Negrín de Gran Canaria, 35010 Las Palmas, Spain.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Castillo-Sainz
authors.affiliation: Internal Medicine Service, Hospital Doctor Negrín de Gran Canaria, 35010 Las Palmas, Spain.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Cárden-Santana
authors.affiliation: Allergy Service, Hospital Doctor Negrín de Gran Canaria, 35010 Las Palmas, Spain.
authors.forename: Teresa
authors.initials: T
authors.lastname: Carrillo-Díaz
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D003429:Cross Reactions; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D000068679:Emtricitabine / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects*; D008875:Middle Aged; D010328:Patch Tests; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine; D000068679:Emtricitabine
keywords: allergy; case report; cutaneous adverse drug reactions; emtricitabine; highly active antiretroviral therapy; hypersensitivity; lamiduvine; patch testing